Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 14, 2011

Drug Name Review Type Class Manufacturer
Complera New Drug Initial Review HIV Gilead
Brilinta New Drug Initial Review Platelet Aggregation Inhibitor AstraZeneca
Edarbi New Drug Initial Review Angiotensin II Receptor Blocker Takeda
Daliresp New Drug Initial Review PDE4 Inhibitor Forest
Pradaxa New Drug Appeal Direct Thrombin Inhibitor Boehringer-Ingelheim
Incivek New Drug Appeal Hepatitis C Vertex
Onglyza New Drug Appeal DPP-4 Inhibitor BMS
Latuda New Drug Appeal Atypical Antipsychotic Sunovion
Exelon Patch PDL Appeal Alzheimers Novartis